Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Muñoz X[au]:

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma. Chapman KR et al. Allergy. (2019)

Occupational lung diseases: from old and novel exposures to effective preventive strategies. Cullinan P et al. Lancet Respir Med. (2017)

Can Environmental Pollution Cause Asthma? Cruz MJ et al. Arch Bronconeumol. (2018)

Search results

Items: 1 to 50 of 166

1.

Hypersensitivity Pneumonitis and (Idiopathic) Pulmonary Fibrosis Due to Feather Duvets and Pillows.

Morell F, Villar A, Ojanguren I, Muñoz X, Cruz MJ, Sansano I, Ramon MA, Raghu G.

Arch Bronconeumol. 2020 Feb 11. pii: S0300-2896(19)30609-X. doi: 10.1016/j.arbres.2019.12.003. [Epub ahead of print] English, Spanish.

2.

Sudan red dye: a new agent causing type-2 occupational asthma.

Clofent D, de Homdedeu M, Muñoz-Esquerre M, Cruz MJ, Muñoz X.

Allergy Asthma Clin Immunol. 2020 Jan 30;16:7. doi: 10.1186/s13223-020-0404-8. eCollection 2020.

3.

Immunomodulatory effect of pigeon serum in an acute and chronic murine model of bird fanciers lung.

Sánchez-Ortiz M, Cruz MJ, Sánchez-Díez S, Villar A, Ojanguren I, Muñoz X.

Environ Res. 2020 Mar;182:108981. doi: 10.1016/j.envres.2019.108981. Epub 2019 Nov 30.

PMID:
31830693
4.

Phenotyping Occupational Asthma Caused by Acrylates in a Multicenter Cohort Study.

Suojalehto H, Suuronen K, Cullinan P, Lindström I, Sastre J, Walusiak-Skorupa J, Munoz X, Talini D, Klusackova P, Moore V, Merget R, Svanes C, Mason P, dell'Omo M, Moscato G, Quirce S, Hoyle J, Sherson D, Preisser A, Seed M, Rifflart C, Godet J, de Blay F, Vandenplas O; European Network for the Phenotyping of Occupational Asthma (E-PHOCAS) investigators.

J Allergy Clin Immunol Pract. 2019 Oct 31. pii: S2213-2198(19)30908-0. doi: 10.1016/j.jaip.2019.10.017. [Epub ahead of print]

PMID:
31678289
5.

Blood eosinophils could be useful as a biomarker in chronic obstructive pulmonary disease exacerbations.

Gonzalez-Barcala FJ, San-Jose ME, Nieto-Fontarigo JJ, Calvo-Alvarez U, Carreira JM, Garcia-Sanz MT, Muñoz X, Perez-Lopez-Corona MP, Gómez-Conde MJ, Casas-Fernández A, Valdes-Cuadrado L, Mateo-Mosquera L, Salgado FJ.

Int J Clin Pract. 2019 Oct 1:e13423. doi: 10.1111/ijcp.13423. [Epub ahead of print]

PMID:
31573721
6.

Addition of Rituximab to Oral Corticosteroids in the Treatment of Chronic Hypersensitivity Pneumonitis.

Morell F, Ojanguren I, Villar A, Ramon MA, Muñoz X, Cruz MJ.

Arch Bronconeumol. 2019 Sep 7. pii: S0300-2896(19)30315-1. doi: 10.1016/j.arbres.2019.07.013. [Epub ahead of print] English, Spanish. No abstract available.

7.

β2-Agonists in Asthma: The Strange case of Dr. Jekyll and Mr. Hyde.

Muñoz X, Romero-Mesones C, Cruz MJ.

Arch Bronconeumol. 2019 Sep 7. pii: S0300-2896(19)30304-7. doi: 10.1016/j.arbres.2019.07.003. [Epub ahead of print] English, Spanish. No abstract available.

8.

rs12416605:C>T in MIR938 associates with gastric cancer through affecting the regulation of the CXCL12 chemokine gene.

Torruella-Loran I, Ramirez Viña MK, Zapata-Contreras D, Muñoz X, Garcia-Ramallo E, Bonet C, Gonzalez CA, Sala N, Espinosa-Parrilla Y; EPIC gastric cancer working group.

Mol Genet Genomic Med. 2019 Aug;7(8):e832. doi: 10.1002/mgg3.832. Epub 2019 Jul 4.

9.

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.

Chapman KR, Albers FC, Chipps B, Muñoz X, Devouassoux G, Bergna M, Galkin D, Azmi J, Mouneimne D, Price RG, Liu MC.

Allergy. 2019 Sep;74(9):1716-1726. doi: 10.1111/all.13850. Epub 2019 Jul 1.

10.

Immunological methods for diagnosis and monitoring of IgE-mediated allergy caused by industrial sensitizing agents (IMExAllergy).

Baur X, Akdis CA, Budnik LT, Cruz MJ, Fischer A, Förster-Ruhrmann U, Göen T, Goksel O, Heutelbeck AR, Jones M, Lux H, Maestrelli P, Munoz X, Nemery B, Schlünssen V, Sigsgaard T, Traidl-Hoffmann C, Siegel P.

Allergy. 2019 Oct;74(10):1885-1897. doi: 10.1111/all.13809. Epub 2019 Jun 27. Review.

11.

Severe Occupational Asthma: Insights From a Multicenter European Cohort.

Vandenplas O, Godet J, Hurdubaea L, Rifflart C, Suojalehto H, Walusiak-Skorupa J, Munoz X, Sastre J, Klusackova P, Moore V, Merget R, Talini D, Kirkeleit J, Mason P, Folletti I, Cullinan P, Moscato G, Quirce S, Hoyle J, Sherson D, Kauppi P, Preisser A, Meyer N, de Blay F; European network for the PHenotyping of OCcupational ASthma (E-PHOCAS) investigators.

J Allergy Clin Immunol Pract. 2019 Sep - Oct;7(7):2309-2318.e4. doi: 10.1016/j.jaip.2019.03.017. Epub 2019 Mar 23.

PMID:
30914232
12.

Relevance of Controling for Confounding in Observational Studies.

Barreiro E, Muñoz X, González-Barcala FJ, Bustamante V, Granda-Orive JI.

Arch Bronconeumol. 2019 Mar;55(3):117. doi: 10.1016/j.arbres.2019.01.001. Epub 2019 Jan 25. English, Spanish. No abstract available.

13.

Concomitant hypersensitivity pneumonitis and occupational asthma caused by 2 different etiologic agents.

Solana E, Cruz MJ, Romero-Mesones C, Muñoz X.

Ann Allergy Asthma Immunol. 2019 Apr;122(4):424-425.e1. doi: 10.1016/j.anai.2019.01.007. Epub 2019 Jan 12. No abstract available.

PMID:
30641195
14.

Diesel exhausts particles: Their role in increasing the incidence of asthma. Reviewing the evidence of a causal link.

Muñoz X, Barreiro E, Bustamante V, Lopez-Campos JL, González-Barcala FJ, Cruz MJ.

Sci Total Environ. 2019 Feb 20;652:1129-1138. doi: 10.1016/j.scitotenv.2018.10.188. Epub 2018 Oct 15. Review.

PMID:
30586799
15.

Long-term outcomes in chronic hypersensitivity pneumonitis.

Ojanguren I, Morell F, Ramón MA, Villar A, Romero C, Cruz MJ, Muñoz X.

Allergy. 2019 May;74(5):944-952. doi: 10.1111/all.13692. Epub 2019 Jan 13.

PMID:
30515826
16.

Identification of Pen m 4 as a potential cause of occupational asthma to Gammarus shrimp.

Sogo A, Cruz MJ, Amengual MJ, Muñoz X.

Clin Transl Allergy. 2018 Nov 9;8:46. doi: 10.1186/s13601-018-0232-9. eCollection 2018.

17.

Typhoid Fever in Chile 1969-2012: Analysis of an Epidemic and Its Control.

Marco C, Delgado I, Vargas C, Muñoz X, Bhutta ZA, Ferreccio C.

Am J Trop Med Hyg. 2018 Sep;99(3_Suppl):26-33. doi: 10.4269/ajtmh.18-0125. Epub 2018 Jul 24.

18.

Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma.

Bernstein DI, Lummus ZL, Kesavalu B, Yao J, Kottyan L, Miller D, Cartier A, Cruz MJ, Lemiere C, Muñoz X, Quirce S, Tarlo S, Sastre J, Boulet LP, Weirauch MT, Kaufman K.

J Allergy Clin Immunol. 2018 Sep;142(3):959-969. doi: 10.1016/j.jaci.2018.06.022. Epub 2018 Jun 30.

PMID:
29969634
19.

Are high- and low-molecular-weight sensitizing agents associated with different clinical phenotypes of occupational asthma?

Vandenplas O, Godet J, Hurdubaea L, Rifflart C, Suojalehto H, Wiszniewska M, Munoz X, Sastre J, Klusackova P, Moore V, Merget R, Talini D, Svanes C, Mason P, dell'Omo M, Cullinan P, Moscato G, Quirce S, Hoyle J, Sherson DL, Kauppi P, Preisser A, Meyer N, de Blay F; European network for the PHenotyping of OCcupational ASthma (E-PHOCAS) investigators.

Allergy. 2019 Feb;74(2):261-272. doi: 10.1111/all.13542. Epub 2018 Nov 25.

20.

Current controversies in the stepping up and stepping down of inhaled therapies for COPD at the patient level.

Lopez-Campos JL, Carrasco Hernández L, Muñoz X, Bustamante V, Barreiro E.

Respirology. 2018 Jun 20. doi: 10.1111/resp.13341. [Epub ahead of print] Review.

21.

The MEGA Project: A Study of the Mechanisms Involved in the Genesis and Disease Course of Asthma. Asthma Cohort Creation and Long-Term Follow-Up.

Muñoz X, Álvarez-Puebla MJ, Arismendi E, Arochena L, Ausín MDP, Barranco P, Bobolea I, Cañas JA, Cardaba B, Crespo A, Del Pozo V, Domínguez-Ortega J, Fernandez-Nieto MDM, Giner J, González-Barcala FJ, Luna JA, Mullol J, Ojanguren I, Olaguibel JM, Picado C, Plaza V, Quirce S, Ramos D, Rial M, Romero-Mesones C, Salgado FJ, San-José ME, Sánchez-Diez S, Sastre B, Sastre J, Soto L, Torrejón M, Urnadoz M, Valdes L, Valero A, Cruz MJ.

Arch Bronconeumol. 2018 Mar 19. pii: S0300-2896(18)30009-7. doi: 10.1016/j.arbres.2017.12.012. [Epub ahead of print] English, Spanish.

22.

Can Environmental Pollution Cause Asthma?

Cruz MJ, Romero-Mesones C, Muñoz X.

Arch Bronconeumol. 2018 Mar;54(3):121-122. doi: 10.1016/j.arbres.2017.08.008. Epub 2017 Nov 6. English, Spanish. No abstract available.

23.

Serum Surfactant Protein D as a Biomarker for Measuring Lung Involvement in Obese Patients With Type 2 Diabetes.

López-Cano C, Lecube A, García-Ramírez M, Muñoz X, Sánchez E, Seminario A, Hernández M, Ciudin A, Gutiérrez L, Hernández C, Simó R.

J Clin Endocrinol Metab. 2017 Nov 1;102(11):4109-4116. doi: 10.1210/jc.2017-00913.

PMID:
28945872
24.

Effects of diesel exhaust particle exposure on a murine model of asthma due to soybean.

Alvarez-Simón D, Muñoz X, Gómez-Ollés S, de Homdedeu M, Untoria MD, Cruz MJ.

PLoS One. 2017 Jun 19;12(6):e0179569. doi: 10.1371/journal.pone.0179569. eCollection 2017.

25.

Asthma exacerbations: risk factors for hospital readmissions.

Gonzalez-Barcala FJ, Calvo-Alvarez U, Garcia-Sanz MT, Garcia-Couceiro N, Martin-Lancharro P, Pose A, Carreira JM, Moure-Gonzalez JD, Valdes-Cuadrado L, Muñoz X.

Ir J Med Sci. 2018 Feb;187(1):155-161. doi: 10.1007/s11845-017-1633-9. Epub 2017 Jun 7.

PMID:
28593573
26.

Effect of anti-IgE in occupational asthma caused by exposure to low molecular weight agents.

Ollé-Monge M, Cruz MJ, Gomez-Ollés S, Ojanguren I, Vanoirbeek J, Muñoz X.

Allergy. 2017 Nov;72(11):1720-1727. doi: 10.1111/all.13190. Epub 2017 Jul 20.

PMID:
28439933
27.

Specific inhalation challenge: the relationship between response, clinical variables and lung function.

Hu C, Cruz MJ, Ojanguren I, de Homdedeu M, Gonzalez-Barcala FJ, Munoz X.

Occup Environ Med. 2017 Aug;74(8):586-591. doi: 10.1136/oemed-2016-103806. Epub 2017 Mar 7.

PMID:
28270447
28.

Asthma exacerbations: factors related to longer hospital stay.

Gonzalez-Barcala FJ, Calvo-Alvarez U, Salgado-Castro FJ, Facal D, Garcia-Sanz MT, Muñoz X, Garcia-Couceiro N, Paz-Neira O, San-Jose E, Valdes-Cuadrado L, Carreira JM.

Acta Clin Belg. 2017 Dec;72(6):379-384. doi: 10.1080/17843286.2017.1295524. Epub 2017 Mar 1.

PMID:
28245723
29.

Occupational lung diseases: from old and novel exposures to effective preventive strategies.

Cullinan P, Muñoz X, Suojalehto H, Agius R, Jindal S, Sigsgaard T, Blomberg A, Charpin D, Annesi-Maesano I, Gulati M, Kim Y, Frank AL, Akgün M, Fishwick D, de la Hoz RE, Moitra S.

Lancet Respir Med. 2017 May;5(5):445-455. doi: 10.1016/S2213-2600(16)30424-6. Epub 2017 Jan 7. Review. Erratum in: Lancet Respir Med. 2017 Jun;5(6):e22.

30.

Prognostic Role of Exhaled Breath Condensate pH and Fraction Exhaled Nitric Oxide in Systemic Sclerosis Related Interstitial Lung Disease.

Guillen-Del Castillo A, Sánchez-Vidaurre S, Simeón-Aznar CP, Cruz MJ, Fonollosa-Pla V, Muñoz X.

Arch Bronconeumol. 2017 Mar;53(3):120-127. doi: 10.1016/j.arbres.2016.09.014. Epub 2016 Dec 27. English, Spanish.

31.

Cranioplasty With Poly-Methyl Methacrylate Resin.

Muñoz XM, Bonardi JP, Silva LF, Reis EN, Pires WR, Fabris AL, Souza FÁ, Garcia Júnior IR.

J Craniofac Surg. 2017 Jan;28(1):294-295. doi: 10.1097/SCS.0000000000003226. No abstract available.

PMID:
27906847
32.

Relationships between chronic obstructive pulmonary disease and lung cancer: biological insights.

Barreiro E, Bustamante V, Curull V, Gea J, López-Campos JL, Muñoz X.

J Thorac Dis. 2016 Oct;8(10):E1122-E1135. Review.

33.

Non-IgE-Mediated Asthma after Zinc Exposure.

Leal A, Caselles I, Rodriguez-Bayarri MJ, Muñoz X.

Arch Bronconeumol. 2017 Jun;53(6):346-347. doi: 10.1016/j.arbres.2016.09.009. Epub 2016 Nov 3. English, Spanish. No abstract available.

34.

Work-Related Asthma: the Dawn of Knowledge?

Cruz MJ, Muñoz X.

Arch Bronconeumol. 2017 Apr;53(4):180-181. doi: 10.1016/j.arbres.2016.08.007. Epub 2016 Oct 19. English, Spanish. No abstract available.

35.

Late mandibular fracture occurring in the postoperative period after third molar removal: systematic review and analysis of 124 cases.

Pires WR, Bonardi JP, Faverani LP, Momesso GA, Muñoz XM, Silva AF, Panzarini SR, Bassi AP, Ponzoni D.

Int J Oral Maxillofac Surg. 2017 Jan;46(1):46-53. doi: 10.1016/j.ijom.2016.09.003. Epub 2016 Sep 28. Review.

PMID:
27688170
36.

Do Low Molecular Weight Agents Cause More Severe Asthma than High Molecular Weight Agents?

Meca O, Cruz MJ, Sánchez-Ortiz M, González-Barcala FJ, Ojanguren I, Munoz X.

PLoS One. 2016 Jun 9;11(6):e0156141. doi: 10.1371/journal.pone.0156141. eCollection 2016.

37.

Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy.

Morell F, Villar A, Ojanguren I, Muñoz X, Cruz MJ.

Semin Respir Crit Care Med. 2016 Jun;37(3):395-405. doi: 10.1055/s-0036-1580692. Epub 2016 May 27. Review.

PMID:
27231863
38.

Persistence of respiratory and inflammatory responses after dermal sensitization to persulfate salts in a mouse model of non-atopic asthma.

Cruz MJ, Olle-Monge M, Vanoirbeek JA, Assialioui A, Gomez-Olles S, Muñoz X.

Allergy Asthma Clin Immunol. 2016 May 24;12:26. doi: 10.1186/s13223-016-0131-3. eCollection 2016.

39.

Postoperative Complications in Craniomaxillofacial Reconstruction With Medpor.

de Moraes Ferreira AC, Muñoz XM, Okamoto R, Pellizer EP, Garcia IR Jr.

J Craniofac Surg. 2016 Mar;27(2):425-8. doi: 10.1097/SCS.0000000000002325. Review.

PMID:
26963299
40.
41.

N-Acetyltransferase 2 Genotypes Are Associated With Diisocyanate-Induced Asthma.

Yucesoy B, Kissling GE, Johnson VJ, Lummus ZL, Gautrin D, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Cruz MJ, Munoz X, Luster MI, Bernstein DI.

J Occup Environ Med. 2015 Dec;57(12):1331-6. doi: 10.1097/JOM.0000000000000561.

42.

Utility of Exhaled Nitric Oxide Fraction for the Diagnosis of Hypersensitivity Pneumonitis.

Ojanguren I, Cruz MJ, Villar A, Barrecheguren M, Morell F, Muñoz X.

Lung. 2016 Feb;194(1):75-80. doi: 10.1007/s00408-015-9824-5. Epub 2015 Nov 13.

PMID:
26566790
43.

Influence of Dopaminergic System Genetic Variation and Lifestyle Factors on Excessive Alcohol Consumption.

Celorrio D, Muñoz X, Amiano P, Dorronsoro M, Bujanda L, Sánchez MJ, Molina-Montes E, Navarro C, Chirlaque MD, MaríaHuerta J, Ardanaz E, Barricarte A, Rodriguez L, Duell EJ, Hijona E, Herreros-Villanueva M, Sala N, Alfonso-Sánchez MA, de Pancorbo MM.

Alcohol Alcohol. 2016 May;51(3):258-67. doi: 10.1093/alcalc/agv114. Epub 2015 Oct 7.

PMID:
26447226
44.

Changes in PH in exhaled breath condensate after specific bronchial challenge test in patients with chronic hypersensitivity pneumonitis: a prospective study.

Ojanguren I, Cruz MJ, Villar A, Sanchez-Ortiz M, Morell F, Munoz X.

BMC Pulm Med. 2015 Sep 30;15:109. doi: 10.1186/s12890-015-0100-5.

45.

Inhalation challenge in the differential diagnosis of usual interstitial pneumonia.

Muñoz X, Sanchez-Ortíz M, Ojanguren I, Cruz MJ.

Eur Respir Rev. 2015 Sep;24(137):542-4. doi: 10.1183/16000617.00000415. No abstract available.

46.

An entomological and seroepidemiological study of the vectorial-transmission risk of Chagas disease in the coast of northern Chile.

González CR, Reyes C, Canals A, Parra A, Muñoz X, Rodríguez K.

Med Vet Entomol. 2015 Dec;29(4):387-92. doi: 10.1111/mve.12131. Epub 2015 Jul 24.

PMID:
26208149
47.

Characteristics and prognosis of near-fatal asthma exacerbations.

Gonzalez-Barcala FJ, Calvo-Alvarez U, Garcia-Sanz MT, Bourdin A, Pose-Reino A, Carreira JM, Moure-Gonzalez JD, Garcia-Couceiro N, Valdes-Cuadrado L, Muñoz X.

Am J Med Sci. 2015 Aug;350(2):98-102. doi: 10.1097/MAJ.0000000000000518.

PMID:
26083648
48.

Genome-Wide Association Study Identifies Novel Loci Associated With Diisocyanate-Induced Occupational Asthma.

Yucesoy B, Kaufman KM, Lummus ZL, Weirauch MT, Zhang G, Cartier A, Boulet LP, Sastre J, Quirce S, Tarlo SM, Cruz MJ, Munoz X, Harley JB, Bernstein DI.

Toxicol Sci. 2015 Jul;146(1):192-201. doi: 10.1093/toxsci/kfv084. Epub 2015 Apr 26.

49.

Incidence and Triggers of Asthma Exacerbations Attended in the Emergency Department as a Level of Care Indicator (ASMAB III, 2005 and ASMAB IV, 2011).

Ojanguren I, Genover T, Muñoz X, Ramon MA, Martínez Moragon E, Morell F.

Arch Bronconeumol. 2016 Feb;52(2):82-7. doi: 10.1016/j.arbres.2015.02.007. Epub 2015 Apr 22. English, Spanish.

50.

Lights and shadows of non-invasive mechanical ventilation for chronic obstructive pulmonary disease (COPD) exacerbations.

Lopez-Campos JL, Jara-Palomares L, Muñoz X, Bustamante V, Barreiro E.

Ann Thorac Med. 2015 Apr-Jun;10(2):87-93. doi: 10.4103/1817-1737.151440. Review.

Supplemental Content

Support Center